In a recent article published in Signal Transduction and Targeted Therapy, researchers extensively reviewed the intricate interactions between gut microbiota and drugs commonly used against several human systemic diseases, e.g., cancer, endocrine disorders, and cardiovascular diseases (CVDs). Background In particular, they focused on investigating the pharmacomicrobiomics of individual variability in drug response (IVDR), the primary cause…
Read more
Exploring the link between drugs and microbiota: a growing imperative in precision medicine





